Data Driven Drug Pricing and More

Data Driven Drug Pricing and More

Value based care means data driven care, whether it be clinical care, drugs, devices or digital therapeutics. Consequently, we are seeing convergent products that not only deliver, but measure the results as part of a whole product solution that drives and measures not only compliance and adherence, but results and pricing.

Here are some other things that should be on your radar screen:

  1. Biomarker driven prescribing
  2. Value based contracting
  3. Data driven drug discovery , design and development
  4. eClinical trials
  5. Patient reported outcomes
  6. Real world evidence derived from data outside of clinical trials
  7. Personalized patient decision support systems
  8. Personalized doctor clinical decision support systems
  9. Blockchain to secure the pharma supply chain
  10. Changing education and training requirements and rethinking medical affairs

Whether you are a patient, a producer or a provider, you will need to learn a new dance because the music is changing. I'm sure their will be a lot of stubbed toes in the process.

Arlen Meyers, MD, MBA is the President and CEO of the Society of Physician Entrepreneurs.

Share this article

Leave your comments

Post comment as a guest

terms and condition.
  • Lisa Bauer

    As a former healthcare worker, I am impressed by your ideas and knowledge on this subject.

  • Caroline Every

    Technology is great, unless it becomes a problem.

Share this article

Arlen Meyers, MD, MBA

Former Contributor

Arlen Meyers, MD, MBA is a professor emeritus of otolaryngology, dentistry, and engineering at the University of Colorado School of Medicine and the Colorado School of Public Health and President and CEO of the Society of Physician Entrepreneurs at He has created several medical device and digital health companies. His primary research centers around biomedical and health innovation and entrepreneurship and life science technology commercialization. He consults for and speaks to companies, governments, colleges and universities around the world who need his expertise and contacts in the areas of bio entrepreneurship, bioscience, healthcare, healthcare IT, medical tourism -- nationally and internationally, new product development, product design, and financing new ventures. He is a former Harvard-Macy fellow and In 2010, he completed a Fulbright at Kings Business, the commercialization office of technology transfer at Kings College in London. He recently published "Building the Case for Biotechnology." "Optical Detection of Cancer", and " The Life Science Innovation Roadmap". He is also an associate editor of the Journal of Commercial Biotechnology and Technology Transfer and Entrepreneurship and Editor-in-Chief of Medscape. In addition, He is a faculty member at the University of Colorado Denver Graduate School where he teaches Biomedical Entrepreneurship and is an iCorps participant, trainer and industry mentor. He is the Chief Medical Officer at and and Chairman of the Board at GlobalMindED at, a non-profit at risk student success network. He is honored to be named by Modern Healthcare as one of the 50 Most Influential Physician Executives of 2011 and nominated in 2012 and Best Doctors 2013.

Cookies user prefences
We use cookies to ensure you to get the best experience on our website. If you decline the use of cookies, this website may not function as expected.
Accept all
Decline all
Read more
Tools used to analyze the data to measure the effectiveness of a website and to understand how it works.
Google Analytics